Abstract
Background The tendency to prefer smaller, immediate rewards over larger, delayed rewards is known as Delay Discounting (DD). Developmental deviations in DD may play a key role in characterizing psychiatric and neurodevelopmental disorders. Recent work provided empirical support for DD as a transdiagnostic process in various psychiatric disorders. However, there is a lack of research relating developmental changes in DD from mid-childhood to adolescence to psychiatric and neurodevelopmental disorders.
Methods The current study addresses this gap in a robust psychiatric sample of 1843 children and adolescents aged 5-18 (M = 10.6, SD = 3.17; 1219 males, 624 females). General Additive Models (GAMs) characterized the shape of age-related changes in monetary and food reward discounting for nine psychiatric disorders compared to neurotypical youth (NT; n=123). We found that over 40% of our sample possessed a minimum of at least three psychiatric or neurodevelopmental disorders. We used bootstrap-enhanced Louvain community detection to map the underlying comorbidity patterns impacting DD. We derived five subtypes based on diagnostic categories present in our sample. DD patterns were then compared across each of the subtypes. Further, we evaluated the effect of cognitive ability, emotional and behavioral problems and total household income (THI) in relation to DD across development.
Results Higher discounting was found in six out of the nine disorders we examined relative to NT. DD was consistently elevated across development for most disorders with the exception of depressive disorders, with age-specific DD differences compared to NTs. Community detection analyses revealed that one comorbidity subtype consisting primarily of Attention-Deficit/Hyperactivity Disorder (ADHD) Combined Presentation and anxiety disorders displayed the highest overall emotional/behavioral problems and greater DD for the food reward. An additional comorbidity subtype composed mainly of ADHD Predominantly Inattentive Presentation, learning and developmental disorders showed the greatest DD for both food and monetary rewards compared to the other subtypes. Notably, this subtype had general deficits in reasoning ability, given their low performance on cognitive and academic achievement measures. Additionally, for this ADHD-I and developmental disorders subtype, THI was related to DD across the age span such that participants with high THI showed no differences in DD compared to NTs, while participants with low THI showed significantly worse DD trajectories than all others. Our results also support prior work showing that DD follows non-linear developmental patterns.
Conclusions We demonstrate preliminary evidence for DD as a transdiagnostic marker of psychiatric and neurodevelopmental disorders in children and adolescents. Comorbidity subtypes provide insight into heterogeneity in DD across disorders and offer a unique way to identify high-risk individuals. Importantly, our findings suggest that DD is strongly related to overall intellectual reasoning ability and that, among those with lower intellectual reasoning, DD is particularly heightened in children from households with lower THI. The findings suggest that self-regulation may be particularly impaired in individuals with psychiatric and neurodevelopmental disorders with low household income.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The work presented here was primarily supported by gifts to the Child Mind Institute from Phyllis Green, Randolph Cowen, and Joseph Healey, as well as NIMH awards U01MH099059 & R01MH091864. The funders for this project were not involved in any part of the experimental design, analysis, and interpretation of data or manuscript preparation and submission.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Chesapeake Institutional Review Board. Written informed consent was obtained from adult participants. For participants younger than 18, written consent was obtained from their guardians, and written assent was obtained from the participant.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos